bionlp-st-ge-2016-spacy-parsed Home  

PMC:1310901 / 13058-14324 JSONTXT 17 Projects

Annnotations TAB TSV DIC JSON TextAE

Id Subject Object Predicate Lexical cue
T6468 0-7 NN denotes Absence
T6469 8-10 IN denotes of
T6470 11-16 NN denotes IRF-4
T6471 17-27 NN denotes expression
T6472 28-30 IN denotes in
T6473 31-39 NN denotes leukemia
T6474 40-45 NNS denotes cells
T6475 46-48 VBZ denotes is
T6476 49-52 RB denotes not
T6477 53-56 JJ denotes due
T6478 57-59 TO denotes to
T6479 60-68 NN denotes promoter
T6480 69-80 NNS denotes alterations
T6481 81-83 PRP denotes We
T6482 84-88 VBP denotes have
T6483 89-99 RB denotes previously
T6484 100-112 VBN denotes demonstrated
T6485 113-114 DT denotes a
T6486 115-119 NN denotes lack
T6487 120-122 IN denotes of
T6488 123-128 NN denotes IRF-4
T6489 129-139 NN denotes expression
T6490 140-142 IN denotes in
T6491 143-151 NN denotes leukemia
T6492 152-160 NNS denotes patients
T6493 161-164 CC denotes and
T6494 165-177 RB denotes specifically
T6495 178-180 IN denotes in
T6496 181-184 NNP denotes CML
T6497 185-192 NNS denotes T-cells
T6498 193-194 -LRB- denotes (
T6499 194-195 CD denotes 3
T6500 195-196 -RRB- denotes )
T6501 196-197 . denotes .
T6502 198-202 RB denotes Here
T6503 202-203 , denotes ,
T6504 204-206 PRP denotes we
T6505 207-218 VBP denotes demonstrate
T6506 219-222 DT denotes the
T6507 223-230 NN denotes absence
T6508 231-233 IN denotes of
T6509 234-239 NN denotes IRF-4
T6510 240-250 NN denotes expression
T6511 251-253 IN denotes in
T6512 254-261 JJ denotes various
T6513 262-275 JJ denotes hematopoietic
T6514 276-280 NN denotes cell
T6515 281-286 NNS denotes lines
T6516 286-287 , denotes ,
T6517 288-292 JJ denotes such
T6518 293-295 IN denotes as
T6519 296-302 NNP denotes Jurkat
T6520 302-303 , denotes ,
T6521 304-305 DT denotes a
T6522 306-312 NNP denotes T-cell
T6523 313-321 NN denotes leukemia
T6524 321-322 , denotes ,
T6525 323-329 NNP denotes CML-T1
T6526 329-330 , denotes ,
T6527 331-332 DT denotes a
T6528 333-349 JJ denotes bcr-abl-positive
T6529 350-356 NNP denotes T-cell
T6530 357-361 NN denotes line
T6531 361-362 , denotes ,
T6532 363-368 NNP denotes K-562
T6533 368-369 , denotes ,
T6534 370-371 DT denotes a
T6535 372-387 JJ denotes bcr-abl-positve
T6536 388-403 NN denotes erythroleukemia
T6537 403-404 , denotes ,
T6538 405-410 NNP denotes U-937
T6539 410-411 , denotes ,
T6540 412-413 DT denotes a
T6541 414-423 JJ denotes monocytic
T6542 424-432 NN denotes leukemia
T6543 432-433 , denotes ,
T6544 434-438 NN denotes EM-2
T6545 439-442 CC denotes and
T6546 443-450 NN denotes LAMA-84
T6547 450-451 , denotes ,
T6548 452-467 JJ denotes bcr-abl-positve
T6549 468-475 JJ denotes myeloid
T6550 476-484 NN denotes leukemia
T6551 484-485 , denotes ,
T6552 486-489 CC denotes but
T6553 490-493 RB denotes not
T6554 494-496 IN denotes in
T6555 497-501 NN denotes SD-1
T6556 501-502 , denotes ,
T6557 503-504 DT denotes a
T6558 505-521 JJ denotes bcr-abl-positive
T6559 522-527 JJ denotes acute
T6560 528-541 JJ denotes lymphoblastic
T6561 542-550 NN denotes leukemia
T6562 551-552 -LRB- denotes (
T6563 552-555 FW denotes pre
T6564 556-561 NNP denotes B-ALL
T6565 561-562 -RRB- denotes )
T6566 562-563 , denotes ,
T6567 564-573 NNP denotes RPMI-8226
T6568 573-574 , denotes ,
T6569 575-576 DT denotes a
T6570 577-585 JJ denotes multiple
T6571 586-593 NN denotes myeloma
T6572 594-597 CC denotes and
T6573 598-604 NN denotes BV-173
T6574 604-605 , denotes ,
T6575 606-607 DT denotes a
T6576 608-624 JJ denotes bcr-abl-positive
T6577 625-631 NNP denotes B-cell
T6578 632-636 NN denotes line
T6579 637-638 -LRB- denotes (
T6580 638-645 NNS denotes Figures
T6581 646-648 NNP denotes 1A
T6582 649-652 CC denotes and
T6583 653-655 NNP denotes 5D
T6584 655-656 -RRB- denotes )
T6585 656-657 . denotes .
T6586 658-663 IN denotes After
T6587 664-674 VBG denotes sequencing
T6588 675-677 IN denotes of
T6589 678-681 DT denotes the
T6590 682-687 NN denotes IRF-4
T6591 688-696 NN denotes promoter
T6592 696-697 , denotes ,
T6593 698-700 PRP denotes it
T6594 701-706 MD denotes could
T6595 707-709 VB denotes be
T6596 710-718 VBN denotes excluded
T6597 719-723 IN denotes that
T6598 724-731 NN denotes absence
T6599 732-734 IN denotes of
T6600 735-740 NN denotes IRF-4
T6601 741-751 NN denotes expression
T6602 752-754 IN denotes in
T6603 755-758 DT denotes any
T6604 759-761 IN denotes of
T6605 762-765 DT denotes the
T6606 766-771 JJ denotes above
T6607 772-776 NN denotes cell
T6608 777-782 NNS denotes lines
T6609 783-786 VBD denotes was
T6610 787-790 JJ denotes due
T6611 791-793 TO denotes to
T6612 794-801 JJ denotes genetic
T6613 802-813 NNS denotes aberrations
T6614 813-814 . denotes .
T6615 815-822 RB denotes However
T6616 822-823 , denotes ,
T6617 824-825 CD denotes 2
T6618 826-828 NN denotes bp
T6619 829-836 NNS denotes changes
T6620 837-838 -LRB- denotes (
T6621 838-848 JJ denotes nucleotide
T6622 849-850 NN denotes −
T6623 850-854 CD denotes 1081
T6624 854-855 , denotes ,
T6625 856-857 NNP denotes T
T6626 857-858 VBD denotes →
T6627 858-859 NNP denotes C
T6628 860-863 CC denotes and
T6629 864-865 NNP denotes −
T6630 865-869 CD denotes 1068
T6631 869-870 , denotes ,
T6632 871-872 DT denotes A
T6633 872-873 NN denotes →
T6634 873-874 NNP denotes C
T6635 874-875 -RRB- denotes )
T6636 876-881 MD denotes could
T6637 882-884 VB denotes be
T6638 885-893 VBN denotes detected
T6639 894-896 IN denotes in
T6640 897-901 DT denotes both
T6641 902-905 DT denotes the
T6642 906-920 JJ denotes IRF-4-positive
T6643 921-927 NN denotes BV-173
T6644 928-931 CC denotes and
T6645 932-935 DT denotes the
T6646 936-950 JJ denotes IRF-4-negative
T6647 951-958 NN denotes LAMA-84
T6648 958-959 , denotes ,
T6649 960-964 NN denotes EM-2
T6650 965-968 CC denotes and
T6651 969-974 NN denotes K-562
T6652 975-976 -LRB- denotes (
T6653 976-982 NN denotes Figure
T6654 983-985 NN denotes 1B
T6655 985-986 -RRB- denotes )
T6656 986-987 . denotes .
T6657 988-990 IN denotes At
T6658 991-999 NN denotes position
T6659 1000-1001 NN denotes −
T6660 1001-1004 CD denotes 116
T6661 1005-1007 DT denotes an
T6662 1008-1009 DT denotes A
T6663 1009-1010 NN denotes →
T6664 1010-1011 NNP denotes C
T6665 1012-1024 NN denotes substitution
T6666 1025-1028 VBD denotes was
T6667 1029-1034 VBN denotes found
T6668 1035-1037 IN denotes in
T6669 1038-1042 NNP denotes EM-2
T6670 1042-1043 , denotes ,
T6671 1044-1049 NNP denotes K-562
T6672 1050-1053 CC denotes and
T6673 1054-1060 NNP denotes CML-T1
T6674 1060-1061 , denotes ,
T6675 1062-1069 IN denotes whereas
T6676 1070-1076 NNP denotes Jurkat
T6677 1076-1077 , denotes ,
T6678 1078-1084 NNP denotes BV-173
T6679 1085-1088 CC denotes and
T6680 1089-1093 NNP denotes SD-1
T6681 1094-1103 VBD denotes exhibited
T6682 1104-1105 DT denotes a
T6683 1106-1111 JJ denotes mixed
T6684 1112-1115 NNP denotes A/C
T6685 1116-1124 NN denotes sequence
T6686 1125-1128 CC denotes and
T6687 1129-1134 NNP denotes U-937
T6688 1134-1135 , denotes ,
T6689 1136-1143 NNP denotes LAMA-84
T6690 1144-1147 CC denotes and
T6691 1148-1157 NNP denotes RPMI-8226
T6692 1158-1160 DT denotes no
T6693 1161-1173 NN denotes substitution
T6694 1174-1176 IN denotes at
T6695 1177-1180 DT denotes all
T6696 1181-1182 -LRB- denotes (
T6697 1182-1188 NN denotes Figure
T6698 1189-1191 NN denotes 1B
T6699 1191-1192 -RRB- denotes )
T6700 1192-1193 . denotes .
T6701 1194-1206 RB denotes Consequently
T6702 1206-1207 , denotes ,
T6703 1208-1213 DT denotes these
T6704 1214-1225 NNS denotes alterations
T6705 1226-1229 VBP denotes are
T6706 1230-1238 JJ denotes unlikely
T6707 1239-1241 TO denotes to
T6708 1242-1248 VB denotes affect
T6709 1249-1254 JJ denotes IRF-4
T6710 1255-1265 NN denotes expression
T6711 1265-1266 . denotes .
R5410 T6468 T6475 nsubj Absence,is
R5411 T6469 T6468 prep of,Absence
R5412 T6470 T6471 compound IRF-4,expression
R5413 T6471 T6469 pobj expression,of
R5414 T6472 T6468 prep in,Absence
R5415 T6473 T6474 compound leukemia,cells
R5416 T6474 T6472 pobj cells,in
R5417 T6475 T6475 ROOT is,is
R5418 T6476 T6475 neg not,is
R5419 T6477 T6475 acomp due,is
R5420 T6478 T6479 aux to,promoter
R5421 T6479 T6477 xcomp promoter,due
R5422 T6480 T6475 conj alterations,is
R5423 T6481 T6484 nsubj We,demonstrated
R5424 T6482 T6484 aux have,demonstrated
R5425 T6483 T6484 advmod previously,demonstrated
R5426 T6484 T6480 relcl demonstrated,alterations
R5427 T6485 T6486 det a,lack
R5428 T6486 T6484 dobj lack,demonstrated
R5429 T6487 T6486 prep of,lack
R5430 T6488 T6489 compound IRF-4,expression
R5431 T6489 T6487 pobj expression,of
R5432 T6490 T6484 prep in,demonstrated
R5433 T6491 T6492 compound leukemia,patients
R5434 T6492 T6490 pobj patients,in
R5435 T6493 T6484 cc and,demonstrated
R5436 T6494 T6495 advmod specifically,in
R5437 T6495 T6484 conj in,demonstrated
R5438 T6496 T6497 compound CML,T-cells
R5439 T6497 T6495 pobj T-cells,in
R5440 T6498 T6497 punct (,T-cells
R5441 T6499 T6497 appos 3,T-cells
R5442 T6500 T6497 punct ),T-cells
R5443 T6501 T6475 punct .,is
R5444 T6502 T6505 advmod Here,demonstrate
R5445 T6503 T6505 punct ",",demonstrate
R5446 T6504 T6505 nsubj we,demonstrate
R5447 T6505 T6505 ROOT demonstrate,demonstrate
R5448 T6506 T6507 det the,absence
R5449 T6507 T6505 dobj absence,demonstrate
R5450 T6508 T6507 prep of,absence
R5451 T6509 T6510 compound IRF-4,expression
R5452 T6510 T6508 pobj expression,of
R5453 T6511 T6507 prep in,absence
R5454 T6512 T6515 amod various,lines
R5455 T6513 T6515 amod hematopoietic,lines
R5456 T6514 T6515 compound cell,lines
R5457 T6515 T6511 pobj lines,in
R5458 T6516 T6515 punct ",",lines
R5459 T6517 T6518 amod such,as
R5460 T6518 T6515 prep as,lines
R5461 T6519 T6518 pobj Jurkat,as
R5462 T6520 T6519 punct ",",Jurkat
R5463 T6521 T6523 det a,leukemia
R5464 T6522 T6523 compound T-cell,leukemia
R5465 T6523 T6519 conj leukemia,Jurkat
R5466 T6524 T6523 punct ",",leukemia
R5467 T6525 T6561 nmod CML-T1,leukemia
R5468 T6526 T6525 punct ",",CML-T1
R5469 T6527 T6530 det a,line
R5470 T6528 T6530 amod bcr-abl-positive,line
R5471 T6529 T6530 compound T-cell,line
R5472 T6530 T6525 appos line,CML-T1
R5473 T6531 T6532 punct ",",K-562
R5474 T6532 T6525 conj K-562,CML-T1
R5475 T6533 T6532 punct ",",K-562
R5476 T6534 T6536 det a,erythroleukemia
R5477 T6535 T6536 amod bcr-abl-positve,erythroleukemia
R5478 T6536 T6532 appos erythroleukemia,K-562
R5479 T6537 T6536 punct ",",erythroleukemia
R5480 T6538 T6536 conj U-937,erythroleukemia
R5481 T6539 T6538 punct ",",U-937
R5482 T6540 T6542 det a,leukemia
R5483 T6541 T6542 amod monocytic,leukemia
R5484 T6542 T6538 appos leukemia,U-937
R5485 T6543 T6542 punct ",",leukemia
R5486 T6544 T6542 conj EM-2,leukemia
R5487 T6545 T6544 cc and,EM-2
R5488 T6546 T6544 conj LAMA-84,EM-2
R5489 T6547 T6546 punct ",",LAMA-84
R5490 T6548 T6550 amod bcr-abl-positve,leukemia
R5491 T6549 T6550 amod myeloid,leukemia
R5492 T6550 T6546 conj leukemia,LAMA-84
R5493 T6551 T6550 punct ",",leukemia
R5494 T6552 T6550 cc but,leukemia
R5495 T6553 T6554 neg not,in
R5496 T6554 T6542 prep in,leukemia
R5497 T6555 T6554 pobj SD-1,in
R5498 T6556 T6554 punct ",",in
R5499 T6557 T6561 det a,leukemia
R5500 T6558 T6561 amod bcr-abl-positive,leukemia
R5501 T6559 T6561 amod acute,leukemia
R5502 T6560 T6561 amod lymphoblastic,leukemia
R5503 T6561 T6523 appos leukemia,leukemia
R5504 T6562 T6564 punct (,B-ALL
R5505 T6563 T6564 compound pre,B-ALL
R5506 T6564 T6561 appos B-ALL,leukemia
R5507 T6565 T6564 punct ),B-ALL
R5508 T6566 T6561 punct ",",leukemia
R5509 T6567 T6561 appos RPMI-8226,leukemia
R5510 T6568 T6567 punct ",",RPMI-8226
R5511 T6569 T6571 det a,myeloma
R5512 T6570 T6571 amod multiple,myeloma
R5513 T6571 T6567 appos myeloma,RPMI-8226
R5514 T6572 T6571 cc and,myeloma
R5515 T6573 T6571 conj BV-173,myeloma
R5516 T6574 T6573 punct ",",BV-173
R5517 T6575 T6578 det a,line
R5518 T6576 T6578 amod bcr-abl-positive,line
R5519 T6577 T6578 compound B-cell,line
R5520 T6578 T6573 appos line,BV-173
R5521 T6579 T6581 punct (,1A
R5522 T6580 T6581 compound Figures,1A
R5523 T6581 T6578 appos 1A,line
R5524 T6582 T6581 cc and,1A
R5525 T6583 T6581 conj 5D,1A
R5526 T6584 T6581 punct ),1A
R5527 T6585 T6505 punct .,demonstrate
R5528 T6586 T6596 prep After,excluded
R5529 T6587 T6586 pcomp sequencing,After
R5530 T6588 T6587 prep of,sequencing
R5531 T6589 T6591 det the,promoter
R5532 T6590 T6591 compound IRF-4,promoter
R5533 T6591 T6588 pobj promoter,of
R5534 T6592 T6596 punct ",",excluded
R5535 T6593 T6596 nsubjpass it,excluded
R5536 T6594 T6596 aux could,excluded
R5537 T6595 T6596 auxpass be,excluded
R5538 T6596 T6596 ROOT excluded,excluded
R5539 T6597 T6598 det that,absence
R5540 T6598 T6596 dobj absence,excluded
R5541 T6599 T6598 prep of,absence
R5542 T6600 T6601 compound IRF-4,expression
R5543 T6601 T6599 pobj expression,of
R5544 T6602 T6596 prep in,excluded
R5545 T6603 T6602 pobj any,in
R5546 T6604 T6603 prep of,any
R5547 T6605 T6608 det the,lines
R5548 T6606 T6608 amod above,lines
R5549 T6607 T6608 compound cell,lines
R5550 T6608 T6604 pobj lines,of
R5551 T6609 T6596 conj was,excluded
R5552 T6610 T6609 acomp due,was
R5553 T6611 T6610 xcomp to,due
R5554 T6612 T6613 amod genetic,aberrations
R5555 T6613 T6611 pobj aberrations,to
R5556 T6614 T6596 punct .,excluded
R5557 T6615 T6638 advmod However,detected
R5558 T6616 T6638 punct ",",detected
R5559 T6617 T6619 nummod 2,changes
R5560 T6618 T6619 compound bp,changes
R5561 T6619 T6638 nsubjpass changes,detected
R5562 T6620 T6619 punct (,changes
R5563 T6621 T6622 amod nucleotide,−
R5564 T6622 T6619 appos −,changes
R5565 T6623 T6622 appos 1081,−
R5566 T6624 T6638 punct ",",detected
R5567 T6625 T6638 nsubj T,detected
R5568 T6626 T6638 parataxis →,detected
R5569 T6627 T6626 dobj C,→
R5570 T6628 T6627 cc and,C
R5571 T6629 T6627 conj −,C
R5572 T6630 T6627 appos 1068,C
R5573 T6631 T6627 punct ",",C
R5574 T6632 T6634 det A,C
R5575 T6633 T6634 compound →,C
R5576 T6634 T6627 appos C,C
R5577 T6635 T6627 punct ),C
R5578 T6636 T6638 aux could,detected
R5579 T6637 T6638 auxpass be,detected
R5580 T6638 T6638 ROOT detected,detected
R5581 T6639 T6638 prep in,detected
R5582 T6640 T6643 preconj both,BV-173
R5583 T6641 T6643 det the,BV-173
R5584 T6642 T6643 compound IRF-4-positive,BV-173
R5585 T6643 T6639 pobj BV-173,in
R5586 T6644 T6643 cc and,BV-173
R5587 T6645 T6647 det the,LAMA-84
R5588 T6646 T6647 amod IRF-4-negative,LAMA-84
R5589 T6647 T6643 conj LAMA-84,BV-173
R5590 T6648 T6647 punct ",",LAMA-84
R5591 T6649 T6647 conj EM-2,LAMA-84
R5592 T6650 T6649 cc and,EM-2
R5593 T6651 T6649 conj K-562,EM-2
R5594 T6652 T6654 punct (,1B
R5595 T6653 T6654 compound Figure,1B
R5596 T6654 T6651 appos 1B,K-562
R5597 T6655 T6654 punct ),1B
R5598 T6656 T6638 punct .,detected
R5599 T6657 T6667 prep At,found
R5600 T6658 T6659 compound position,−
R5601 T6659 T6657 pobj −,At
R5602 T6660 T6659 nummod 116,−
R5603 T6661 T6665 det an,substitution
R5604 T6662 T6665 det A,substitution
R5605 T6663 T6665 amod →,substitution
R5606 T6664 T6665 compound C,substitution
R5607 T6665 T6667 nsubjpass substitution,found
R5608 T6666 T6667 auxpass was,found
R5609 T6667 T6667 ROOT found,found
R5610 T6668 T6667 prep in,found
R5611 T6669 T6668 pobj EM-2,in
R5612 T6670 T6669 punct ",",EM-2
R5613 T6671 T6669 conj K-562,EM-2
R5614 T6672 T6671 cc and,K-562
R5615 T6673 T6671 conj CML-T1,K-562
R5616 T6674 T6667 punct ",",found
R5617 T6675 T6681 mark whereas,exhibited
R5618 T6676 T6681 nsubj Jurkat,exhibited
R5619 T6677 T6676 punct ",",Jurkat
R5620 T6678 T6676 conj BV-173,Jurkat
R5621 T6679 T6678 cc and,BV-173
R5622 T6680 T6678 conj SD-1,BV-173
R5623 T6681 T6667 advcl exhibited,found
R5624 T6682 T6685 det a,sequence
R5625 T6683 T6685 amod mixed,sequence
R5626 T6684 T6685 compound A/C,sequence
R5627 T6685 T6681 dobj sequence,exhibited
R5628 T6686 T6685 cc and,sequence
R5629 T6687 T6685 conj U-937,sequence
R5630 T6688 T6687 punct ",",U-937
R5631 T6689 T6687 conj LAMA-84,U-937
R5632 T6690 T6689 cc and,LAMA-84
R5633 T6691 T6689 conj RPMI-8226,LAMA-84
R5634 T6692 T6693 det no,substitution
R5635 T6693 T6685 conj substitution,sequence
R5636 T6694 T6695 advmod at,all
R5637 T6695 T6693 advmod all,substitution
R5638 T6696 T6698 punct (,1B
R5639 T6697 T6698 compound Figure,1B
R5640 T6698 T6693 appos 1B,substitution
R5641 T6699 T6698 punct ),1B
R5642 T6700 T6667 punct .,found
R5643 T6701 T6705 advmod Consequently,are
R5644 T6702 T6705 punct ",",are
R5645 T6703 T6704 det these,alterations
R5646 T6704 T6705 nsubj alterations,are
R5647 T6705 T6705 ROOT are,are
R5648 T6706 T6705 acomp unlikely,are
R5649 T6707 T6708 aux to,affect
R5650 T6708 T6706 xcomp affect,unlikely
R5651 T6709 T6710 amod IRF-4,expression
R5652 T6710 T6708 dobj expression,affect
R5653 T6711 T6705 punct .,are